Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.59 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.59 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.54 |
| ▸ | NQO2 | P16083 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | HPGD | P15428 | 3/20 | 0.54 |
| ▸ | HTT | P42858 | 2/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | GLA | P06280 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | CASP1 | P29466 | 1/20 | 0.54 |
| ▸ | CASP7 | P55210 | 1/20 | 0.54 |
| ▸ | ATM | Q13315 | 1/20 | 0.54 |
| ▸ | GPR3 | P46089 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28691180 | 0.86 | KDM4E (0.63) | CYP19A1NQO2KDM4EALDH1A1HPGD | |
| SCHEMBL20650932 | 0.86 | CYP19A1 (0.62) | CYP19A1NQO2KDM4EALDH1A1HPGD | |
| SCHEMBL4373659 | 0.83 | CYP19A1 (0.53) | ALKBH5FTOCYP19A1NQO2KDM4E | |
| SCHEMBL15466278 | 0.81 | ALKBH5 (0.54) | ALKBH5FTOKDM4EALDH1A1HPGD | |
| SCHEMBL24311758 | 0.80 | KDM4E (0.53) | ALKBH5FTOCYP19A1NQO2KDM4E | |
| SCHEMBL28606326 | 0.80 | CYP19A1 (0.41) | ALKBH5FTOCYP19A1NQO2KDM4E | |
| SCHEMBL31515799 | 0.80 | ALKBH5 (0.57) | ALKBH5FTOCYP19A1NQO2KDM4E | |
| SCHEMBL28984467 | 0.80 | ALKBH5 (0.53) | ALKBH5FTOKDM4EALDH1A1HPGD | |
| SCHEMBL15465966 | 0.78 | GPR3 (0.54) | CYP19A1NQO2KDM4EALDH1A1HPGD | |
| SCHEMBL3423943 | 0.78 | GPR3 (0.71) | ALKBH5FTONQO2KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230225147-A1 | ORGANIC LIGHT-EMITTING ELEMENT | KYULUX, INC. (JP) | 2023-07-13 | — | — | US | disclosed |
| US-20230225147-A1 | ORGANIC LIGHT-EMITTING ELEMENT | KYULUX, INC. (JP) | 2023-07-13 | — | — | US | disclosed |
| US-11335872-B2 | Organic light-emitting device | KYULUX, INC. (JP) | 2022-05-17 | — | — | US | disclosed |
| US-20220069241-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2022-03-03 | — | — | US | disclosed |
| US-20210234113-A1 | ORGANIC LIGHT-EMITTING DEVICE | KYULUX, INC. (JP) | 2021-07-29 | — | — | US | disclosed |
| US-20200259112-A1 | ORGANIC LIGHT-EMITTING ELEMENT | KYULUX, INC. (JP) | 2020-08-13 | — | — | US | disclosed |
| US-10510977-B2 | Compound, light-emitting material, and organic light-emitting device | KYULUX, INC. (JP) | 2019-12-17 | — | — | US | disclosed |
| US-20190221749-A1 | CHARGE TRANSPORT MATERIAL, COMPOUND, DELAYED FLUORESCENT MATERIAL AND ORGANIC LIGHT EMITTING ELEMENT | KYULUX, INC. (JP) | 2019-07-18 | — | — | US | disclosed |
| US-20190016704-A1 | COMPOUND, LIGHT-EMITTING MATERIAL, AND ORGANIC LIGHT-EMITTING DEVICE | KYULUX, INC. (JP) | 2019-01-17 | — | — | US | disclosed |
| US-10043978-B2 | Organic semiconductor formulations | FLEXTERRA, INC. (US) | 2018-08-07 | — | — | US | disclosed |
| US-20170012208-A1 | ORGANIC SEMICONDUCTOR FORMULATIONS | USINVEST LLC | 2017-01-12 | — | — | US | disclosed |
| US-9293711-B2 | Organic semiconductor formulations | POLYERA CORPORATION (US) | 2016-03-22 | — | — | US | disclosed |
| US-20140042369-A1 | Organic Semiconductor Formulations | USINVEST LLC | 2014-02-13 | — | — | US | disclosed |
| US-20080146810-A1 | NOVEL TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | GLENMARK PHARMACEUTICALS S.A. (CH) | 2008-06-19 | — | — | US | disclosed |
| EP-1554262-B1 | NOVEL TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | GLENMARK PHARMACEUTICALS LTD (IN) | 2007-12-05 | — | — | EP | disclosed |
| US-7238725-B2 | Tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them | GLENMARK PHARMACEUTICALS LTD. (IN) | 2007-07-03 | — | — | US | disclosed |
| US-20060178418-A1 | Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders:process for their preparation and pharmaceutical compositions containing them | GLENMARK PHARMACEUTICALS LTD. (IN) | 2006-08-10 | — | — | US | disclosed |
| EP-1554262-A1 | NOVEL TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Glenmark Pharmaceuticals Limited (IN) | 2005-07-20 | — | — | EP | disclosed |
| WO-2004037805-A1 | NOVEL TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | GLENMARK PHARMACEUTICALS LTD. (US) | 2004-05-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080146810-A1 | NOVEL TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | LTC4S, TSLP, GPR119 | ALKBH5 4786/4885FTO 4525/4885CYP19A1 248/4885 |
| US-20190016704-A1 | COMPOUND, LIGHT-EMITTING MATERIAL, AND ORGANIC LIGHT-EMITTING DEVICE | CRY1, CRY2, CYBA | ALKBH5 3225/4885FTO 1419/4885CYP19A1 2109/4885 |
| US-20060178418-A1 | Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders:process for their preparation and pharmaceutical compositions containing them | LTC4S, TSLP, GPR119 | ALKBH5 4786/4885FTO 4525/4885CYP19A1 248/4885 |
| US-20220069241-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | CHRM1, LBR, CNKSR1 | ALKBH5 2639/4885FTO 1305/4885CYP19A1 2133/4885 |
| US-20190221749-A1 | CHARGE TRANSPORT MATERIAL, COMPOUND, DELAYED FLUORESCENT MATERIAL AND ORGANIC LIGHT EMITTING ELEMENT | SLC43A1, SLC7A5, SLC39A3 | ALKBH5 4113/4885FTO 1823/4885CYP19A1 1813/4885 |
| US-10510977-B2 | Compound, light-emitting material, and organic light-emitting device | CRY1, CRY2, CYBA | ALKBH5 3225/4885FTO 1419/4885CYP19A1 2109/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.